Botox Competitor Aims to Take Market Share as Allergan Stumbles

(Bloomberg) -- An upstart company with a competitor to Allergan Plc’s Botox has its eye on becoming the next wrinkle treatment of choice.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.